Article thumbnail

Curative treatment of oesophageal carcinoma: current options and future developments

By Maria C Wolf, Michael Stahl, Bernd J Krause, Luigi Bonavina, Christiane Bruns, Claus Belka and Franz Zehentmayr

Abstract

Since the 1980s major advances in surgery, radiotherapy and chemotherapy have established multimodal approaches as curative treatment options for oesophageal cancer. In addition the introduction of functional imaging modalities such as PET-CT created new opportunities for a more adequate patient selection and therapy response assessment

Topics: Short Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3127782
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2011). al: Traditional invasive vs. minimally invasive esophagectomy: a multi-centered, randomized trial (TIME-trial). BMC Surg
  2. (2003). AS: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol
  3. (1992). Banting S: Endoscopic oesophagectomy through a right thoracoscopic approach.
  4. (2005). Birkmeyer JD: Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery
  5. (2004). Camma C: Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut
  6. (2006). Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev
  7. (1992). Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.
  8. (2005). Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.
  9. (2005). Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg
  10. (2005). EK: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg
  11. (1978). Esophagectomy without thoracotomy.
  12. (2007). et al: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol
  13. (2005). et al: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
  14. (1999). et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA
  15. (1998). et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
  16. (2001). et al: Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors.
  17. (2002). et al: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.
  18. (1998). et al: Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys
  19. (2008). et al: Recommendations on the use of 18F-FDG PET in oncology.
  20. (2005). et al: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol
  21. (2007). et al: Surgical treatment for esophageal cancer. Current issues. Dig Surg
  22. (2009). Evidence-based radiation oncology: oesophagus. Radiother Oncol
  23. (2003). FL: Surgeon volume and operative mortality in the United States.
  24. (1995). Grecco E: Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc
  25. (2003). H: Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc
  26. (2003). HC: Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg
  27. (1991). HD: Training program for minimally invasive surgery. Chirurg
  28. (1996). Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.
  29. (2001). Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg
  30. (2005). HJ: Esophagectomy as therapeutic principle for squamous cell esophageal cancer. Chirurg
  31. (2002). Kelsen DP: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
  32. (2009). Koong AC: Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
  33. (2004). Neoadjuvante Radiochemotherapie und Responseprädiktion. Onkologe
  34. (2004). Peracchia A: A laparoscopy-assisted surgical approach to esophageal carcinoma.
  35. (2003). Peracchia A: Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus
  36. (2004). Peracchia A: Esophagectomy via laparoscopy and transmediastinal endodissection. J Laparoendosc Adv Surg Tech A
  37. (2002). Peracchia A: Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett’s esophagus. Surg Endosc
  38. (1997). Peracchia A: Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction. J Surg Oncol
  39. (2007). PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol
  40. (2008). Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol
  41. (1998). Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.
  42. (1998). S: A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus.
  43. (2009). Selected commentary to “Fifty-five minimally invasive esophagectomies: a single center experience”. Eur Surg
  44. (2001). Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg
  45. (2008). Siersema PD: Staging investigations for oesophageal cancer: a meta-analysis.
  46. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol
  47. (2007). Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg
  48. (2001). Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg
  49. (2007). Triboulet JP: Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol
  50. (1999). Tsuburaya A: High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. Cancer Lett
  51. (2003). Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
  52. (2006). Venkatachlam S: Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position–experience of 130 patients. JA m Coll Surg
  53. (2009). zum Buschenfelde CM: 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.